Clinical Trials Directory

Trials / Completed

CompletedNCT05772988

Beta-alanine Supplementation and CrossFit Performance

Examining the Effects of 3-weeks Beta-Alanine Supplementation on CrossFit® Performance

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
University of Saskatchewan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study will randomize CrossFit participants to receive beta-alanine or placebo supplementation for 3 weeks. The study will be double-blind. Performance on the "Fran" test will be completed at baseline and after the 3 week intervention. Respiratory exchange ratio will also be assessed during the performance test at baseline and after 3 weeks.

Detailed description

Beta-alanine is a nutritional supplement often consumed by people involved in high-intensity sports that involve substantial lactic acidosis. If consumed on a regular basis, it improves muscle buffering capacity and exercise performance during high-intensity moderate-duration events. CrossFit involves competitions that are high in intensity and moderate duration and many elite CrossFit athletes have reported taking beta-alanine as a supplement. It has never however been evaluated in a research study for its affect on CrossFit performance. The purpose of the study is therefore to assess the effects of beta-alanine supplementation on CrossFit performance. A maximum of 30 CrossFit participants will participate in this randomized double-blind parallel groups study. Participants will be randomized to receive 6.4 g/d beta-alanine or maltodextrin placebo for 3 weeks. At baseline and after the intervention, participants will complete a "Fran" test, which involves performing sets of repeated dumbbell thrusters alternating with chin-ups. The performance measure is the time to complete the test. During the test, respiratory exchange ratio will be assessed to indirectly assess acidosis.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBeta-alanineBeta-alanine
DIETARY_SUPPLEMENTMaltodextrinMaltodextrin

Timeline

Start date
2023-03-15
Primary completion
2023-08-31
Completion
2023-08-31
First posted
2023-03-17
Last updated
2024-05-29

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05772988. Inclusion in this directory is not an endorsement.